New answer by Radiation Oncologist at Vanderbilt-Ingram Cancer Center (October 6, 2022)
The 2011 WBI guidelines had a lack of consensus of the best hypoFX regimen in the chemotherapy era given a paucity of research on the safety of the hypoFX regimen back when th...